Anodyne Nanotech: Funding, Investors & Team (Sep 2026)
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs. Its first practical and cost-effective platform, Hero Patch, delivers clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules for fast and sustained delivery. The company was founded in 2019 by Jake Lombardo, Konstantinos Tzortzakis, and Hojatollah Rezaei Nejad.
Anodyne Nanotech has raised $16.8M across 2 funding rounds on record, the most recent a Series A of $12.6M announced in Jun 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Anodyne Nanotech Company Profile and Key Stats
Latest funding round on record: Jun 2026.
Anodyne Nanotech Funding Rounds
Anodyne Nanotech raised $4.2M in an undisclosed round announced in May 2021.
5.1 years later, a Series A of $12.6M was announced in Jun 2026.
Anodyne Nanotech Founders and Leadership Team
Contact details for the Anodyne Nanotech team: 1 of 1 has an email address on file.
Start 14-day free trial →Anodyne Nanotech Funding Compared to Other Biotechnology Startups
Anodyne Nanotech's latest round of $12.6M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Anodyne Nanotech in Biotechnology and Boston
Companies Similar to Anodyne Nanotech
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Anodyne Nanotech Funding FAQs
What does Anodyne Nanotech do?
Anodyne Nanotech is a preclinical-stage biotech company that develops differentiated, transdermal forms of high-value drugs. Its first practical and cost-effective platform, Hero Patch, delivers clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules for fast and sustained delivery. The company was founded in 2019 by Jake Lombardo, Konstantinos Tzortzakis, and Hojatollah Rezaei Nejad.
How much funding has Anodyne Nanotech raised?
Anodyne Nanotech has raised $16.8M across 2 rounds on record. The most recent is a Series A of $12.6M announced in Jun 2026.
When did Anodyne Nanotech last raise funding?
Anodyne Nanotech's most recent funding round on record is a Series A of $12.6M, announced in Jun 2026.
Who is the CEO of Anodyne Nanotech?
Jake Lombardo is listed as CEO at Anodyne Nanotech.
Where is Anodyne Nanotech headquartered?
Anodyne Nanotech is based in Boston, Massachusetts, United States.
How many employees does Anodyne Nanotech have?
Anodyne Nanotech is in the 11-50 employee band.
How does Anodyne Nanotech's funding compare to other Biotechnology startups?
Anodyne Nanotech's latest round of $12.6M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Anodyne Nanotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Anodyne Nanotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.